Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
192.50
-2.00 (-1.03%)
Sep 5, 2025, 1:30 PM CST

Lotus Pharmaceutical Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Cash & Equivalents
4,1136,0301,7711,9831,6051,489
Upgrade
Cash & Short-Term Investments
4,1136,0301,7711,9831,6051,489
Upgrade
Cash Growth
44.01%240.51%-10.71%23.54%7.82%16.61%
Upgrade
Accounts Receivable
6,4137,4356,3844,6513,2662,747
Upgrade
Other Receivables
166.36268.54233.13276.24141.5653.19
Upgrade
Receivables
6,5807,7036,6174,9273,4072,801
Upgrade
Inventory
3,8913,8333,7753,3303,0732,208
Upgrade
Other Current Assets
521.37531.5489.37420.4247.24284.61
Upgrade
Total Current Assets
15,10518,09812,65310,6618,3336,783
Upgrade
Property, Plant & Equipment
3,5533,6663,5113,1482,6422,305
Upgrade
Long-Term Investments
3,2083,5943,0482,158301.73412.85
Upgrade
Goodwill
6,0176,1275,6705,6685,5865,896
Upgrade
Other Intangible Assets
6,2175,1995,4875,9102,9713,177
Upgrade
Long-Term Accounts Receivable
122.29122.73152.6---
Upgrade
Long-Term Deferred Tax Assets
513.4486.42411.69390.12310.82364.61
Upgrade
Long-Term Deferred Charges
3,2652,6391,8781,406891.98654.1
Upgrade
Other Long-Term Assets
163.19168.74180.28185.33185.35161.12
Upgrade
Total Assets
38,16440,10132,99229,52621,22219,753
Upgrade
Accounts Payable
919.291,070670.81,403747.551,732
Upgrade
Accrued Expenses
--3.063.570.932.46
Upgrade
Short-Term Debt
1,2161,615510155.921,377410
Upgrade
Current Portion of Long-Term Debt
4,2213,3901,30359.95794.91,359
Upgrade
Current Portion of Leases
87.2684.3270.2458.9962.4740.43
Upgrade
Current Income Taxes Payable
468.19664.47436.56731.15280.16226.62
Upgrade
Current Unearned Revenue
167.88180.9132.85183.08132.01132.1
Upgrade
Other Current Liabilities
2,6901,4331,3983,297931.26980.66
Upgrade
Total Current Liabilities
9,7698,4384,5245,8934,3264,883
Upgrade
Long-Term Debt
5,9518,3849,5198,5964,6674,948
Upgrade
Long-Term Leases
142.45194.06182.246.8243.4176.58
Upgrade
Long-Term Unearned Revenue
20.7626.5645.3365.9285.96111.78
Upgrade
Long-Term Deferred Tax Liabilities
1,0911,093721.2448.4304.15144.69
Upgrade
Other Long-Term Liabilities
160.78112.17162.29235.84224.03257.46
Upgrade
Total Liabilities
17,80018,92115,65815,65810,15311,008
Upgrade
Common Stock
2,6702,6592,6502,6262,6282,454
Upgrade
Additional Paid-In Capital
7,6637,4317,1317,5348,0396,799
Upgrade
Retained Earnings
13,30412,6608,9004,8231,701353.66
Upgrade
Treasury Stock
-824.16-48.39-51.1-57.35-57.75-
Upgrade
Comprehensive Income & Other
-2,450-1,521-1,295-1,058-1,241-860.97
Upgrade
Total Common Equity
20,36421,18017,33413,86811,0698,745
Upgrade
Shareholders' Equity
20,36421,18017,33413,86811,0698,745
Upgrade
Total Liabilities & Equity
38,16440,10132,99229,52621,22219,753
Upgrade
Total Debt
11,61713,66711,5858,9186,9446,834
Upgrade
Net Cash (Debt)
-7,504-7,636-9,814-6,935-5,339-5,345
Upgrade
Net Cash Per Share
-28.53-28.99-37.45-26.50-20.80-21.95
Upgrade
Filing Date Shares Outstanding
262.98265.39264.47262.04262.25245.35
Upgrade
Total Common Shares Outstanding
262.98265.39264.47262.04262.25245.35
Upgrade
Working Capital
5,3369,6608,1294,7684,0071,900
Upgrade
Book Value Per Share
77.4479.8165.5452.9242.2135.64
Upgrade
Tangible Book Value
8,1309,8556,1772,2912,512-327.16
Upgrade
Tangible Book Value Per Share
30.9237.1323.368.749.58-1.33
Upgrade
Land
585.72599.33622.55622.31615.49654.22
Upgrade
Buildings
2,1002,0741,8881,3841,3131,012
Upgrade
Machinery
1,9821,8651,8261,5471,4081,324
Upgrade
Construction In Progress
592.13706.38639.411,077675.22608.86
Upgrade
Leasehold Improvements
77.98100.1571.0187.8778.2685.33
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.